Atlas Trials

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Clinical trial NCT01157039 · WITHDRAWN

Trial details

NCT number
NCT01157039
Sponsor
AHS Cancer Control Alberta
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal CarcinomaNeoplasms, ColorectalColorectal CancerColorectal TumorsMetastasis
Start date
2011-10-01
Primary completion
2012-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.